Onya Therapeutics is a wound therapeutics company, building a pipeline of products that will redefine the standard of care. These products will improve patients’ quality of life, reduce the dependence on the use of antibiotics and address the issue of antimicrobial resistance in wounds.

Currently focussing on pre-clinical development activities to advance its first asset to clinical trial for chronic wounds that are on a delayed wound healing trajectory.

Additional pipeline technologies will result in further therapeutic interventions to redefine the standard of care of wounds in several areas and contribute to the scientific understanding of wound healing and infection.